Table 1.
Patient clinical characteristics and echocardiographic parameters
| Non-CAD group | CAD group | p-value | |
|---|---|---|---|
| (n = 26) | (n = 59) | ||
| Clinical characteristics | |||
| Men (%) | 20 (76.9) | 39 (66.1) | 0.27 |
| Age, years | 62 ± 15 | 69 ± 9 | 0.007 |
| Body mass index | 22.7 ± 3.1 | 23.8 ± 3.0 | 0.12 |
| Hypertension, n (%) | 12 (46.1) | 36 (61.0) | 0.15 |
| Diabetes mellitus, n (%) | 5 (19.2) | 28 (47.5) | 0.010 |
| Dyslipidemia, n (%) | 5 (19.2) | 32 (56.1) | 0.002 |
| Systolic blood pressure (mmHg) | 125 ± 18 | 130 ± 18 | 0.21 |
| Diastolic blood pressure (mmHg) | 75 ± 11 | 75 ± 12 | 0.85 |
| Echocardiographic parameters | |||
| Left ventricular ejection fraction (%) | 70 ± 6 | 62 ± 11 | 0.001 |
| LVEDd (mm) | 45 ± 7 | 47 ± 5 | 0.15 |
| LVSWth (mm) | 9.2 ± 1.7 | 9.5 ± 1.3 | 0.41 |
| LVPWth (mm) | 9.6 ± 1.5 | 9.7 ± 1.5 | 0.72 |
| Medications | |||
| ARBs or ACEIs, n (%) | 8 (30.8) | 16 (27.1) | 0.81 |
| Beta-blockers, n (%) | 3 (11.5) | 9 (15.2) | 0.61 |
| Calcium channel blockers, n (%) | 7 (26.9) | 23 (39.0) | 0.23 |
| Diuretics, n (%) | 2 (7.7) | 7 (11.9) | 0.71 |
LVEDd: Left ventricular end-diastolic dimension, LVSWth: left ventricular septal wall thickness, LVPWth: left ventricular posterior wall thickness, ACEIs: angiotensin-converting enzyme inhibitors, ARBs: Angiotensin II receptor blockers